Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aggression | 51 | 2023 | 330 | 8.280 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 33 | 2023 | 286 | 5.660 |
Why?
|
| Personality Disorders | 27 | 2020 | 145 | 4.740 |
Why?
|
| Impulsive Behavior | 26 | 2018 | 290 | 3.570 |
Why?
|
| Lysergic Acid Diethylamide | 8 | 2024 | 27 | 1.800 |
Why?
|
| Hallucinogens | 9 | 2024 | 84 | 1.640 |
Why?
|
| Anger | 8 | 2021 | 81 | 1.410 |
Why?
|
| Oxytocin | 9 | 2023 | 75 | 1.270 |
Why?
|
| Emotions | 12 | 2024 | 377 | 1.240 |
Why?
|
| Serotonin | 11 | 2015 | 219 | 1.220 |
Why?
|
| Adult | 81 | 2025 | 28716 | 1.170 |
Why?
|
| Social Perception | 5 | 2022 | 94 | 1.140 |
Why?
|
| Psychiatric Status Rating Scales | 21 | 2016 | 504 | 1.050 |
Why?
|
| Young Adult | 41 | 2025 | 7025 | 1.040 |
Why?
|
| Emotional Intelligence | 3 | 2016 | 22 | 1.010 |
Why?
|
| Psychometrics | 4 | 2016 | 340 | 0.940 |
Why?
|
| Child Abuse | 5 | 2014 | 94 | 0.940 |
Why?
|
| Borderline Personality Disorder | 4 | 2020 | 36 | 0.930 |
Why?
|
| Corticotropin-Releasing Hormone | 4 | 2011 | 44 | 0.890 |
Why?
|
| Affect | 7 | 2023 | 397 | 0.860 |
Why?
|
| Substance-Related Disorders | 3 | 2021 | 451 | 0.860 |
Why?
|
| Male | 76 | 2025 | 45870 | 0.850 |
Why?
|
| Methamphetamine | 5 | 2025 | 104 | 0.810 |
Why?
|
| Growth Hormone | 2 | 2015 | 99 | 0.800 |
Why?
|
| Female | 68 | 2025 | 50030 | 0.750 |
Why?
|
| Homovanillic Acid | 3 | 2012 | 35 | 0.740 |
Why?
|
| Mental Health Services | 1 | 2023 | 78 | 0.740 |
Why?
|
| Hydroxyindoleacetic Acid | 3 | 2012 | 26 | 0.730 |
Why?
|
| Antipsychotic Agents | 1 | 2023 | 151 | 0.710 |
Why?
|
| Hostility | 3 | 2021 | 25 | 0.690 |
Why?
|
| Humans | 91 | 2025 | 96093 | 0.690 |
Why?
|
| Brain | 12 | 2025 | 2482 | 0.680 |
Why?
|
| Parent-Child Relations | 3 | 2015 | 83 | 0.680 |
Why?
|
| Social Behavior | 5 | 2024 | 309 | 0.670 |
Why?
|
| Interpersonal Relations | 2 | 2024 | 182 | 0.650 |
Why?
|
| Benzazepines | 1 | 2019 | 65 | 0.610 |
Why?
|
| Surveys and Questionnaires | 10 | 2021 | 2860 | 0.590 |
Why?
|
| Cognition | 4 | 2022 | 635 | 0.580 |
Why?
|
| Double-Blind Method | 15 | 2025 | 1791 | 0.580 |
Why?
|
| Statistics as Topic | 6 | 2015 | 236 | 0.580 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 4 | 2024 | 74 | 0.570 |
Why?
|
| Affective Symptoms | 2 | 2018 | 56 | 0.560 |
Why?
|
| Fluoxetine | 4 | 2015 | 42 | 0.560 |
Why?
|
| Violence | 1 | 2020 | 154 | 0.560 |
Why?
|
| Endocannabinoids | 1 | 2018 | 27 | 0.550 |
Why?
|
| Comorbidity | 8 | 2020 | 1011 | 0.510 |
Why?
|
| Perforant Pathway | 1 | 2016 | 6 | 0.500 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2015 | 7 | 0.480 |
Why?
|
| Clonidine | 1 | 2015 | 34 | 0.480 |
Why?
|
| Middle Aged | 28 | 2021 | 28361 | 0.470 |
Why?
|
| White Matter | 1 | 2016 | 96 | 0.460 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 1981 | 0.450 |
Why?
|
| Reward | 4 | 2025 | 209 | 0.430 |
Why?
|
| Craving | 3 | 2020 | 24 | 0.430 |
Why?
|
| Object Attachment | 1 | 2014 | 20 | 0.430 |
Why?
|
| Smokers | 3 | 2020 | 55 | 0.420 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2016 | 341 | 0.420 |
Why?
|
| Dronabinol | 3 | 2024 | 59 | 0.410 |
Why?
|
| Personality Inventory | 6 | 2015 | 112 | 0.400 |
Why?
|
| Amygdala | 3 | 2019 | 87 | 0.380 |
Why?
|
| Hydrocortisone | 2 | 2011 | 300 | 0.380 |
Why?
|
| Wounds and Injuries | 1 | 2015 | 283 | 0.370 |
Why?
|
| Mental Processes | 1 | 2012 | 32 | 0.370 |
Why?
|
| Mood Disorders | 1 | 2012 | 83 | 0.360 |
Why?
|
| Pituitary-Adrenal Function Tests | 1 | 2011 | 2 | 0.350 |
Why?
|
| Spinal Puncture | 8 | 2015 | 39 | 0.350 |
Why?
|
| Adolescent | 14 | 2022 | 9896 | 0.350 |
Why?
|
| Suicide | 2 | 2016 | 162 | 0.340 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2011 | 132 | 0.340 |
Why?
|
| GABA-B Receptor Agonists | 1 | 2010 | 5 | 0.340 |
Why?
|
| Receptors, GABA-B | 1 | 2010 | 9 | 0.340 |
Why?
|
| Baclofen | 1 | 2010 | 16 | 0.340 |
Why?
|
| Electroencephalography | 5 | 2024 | 824 | 0.340 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 12 | 2015 | 224 | 0.330 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2016 | 125 | 0.310 |
Why?
|
| Life Change Events | 3 | 2006 | 50 | 0.310 |
Why?
|
| Oxidative Stress | 3 | 2020 | 483 | 0.310 |
Why?
|
| Healthy Volunteers | 4 | 2023 | 157 | 0.300 |
Why?
|
| Alcohol Drinking | 2 | 2024 | 287 | 0.300 |
Why?
|
| Spouse Abuse | 1 | 2008 | 13 | 0.290 |
Why?
|
| Suicide, Attempted | 4 | 2016 | 140 | 0.290 |
Why?
|
| Tobacco Products | 2 | 2020 | 80 | 0.290 |
Why?
|
| Analysis of Variance | 6 | 2016 | 910 | 0.290 |
Why?
|
| Tryptophan | 3 | 2016 | 105 | 0.280 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2008 | 87 | 0.270 |
Why?
|
| Central Nervous System Stimulants | 3 | 2025 | 235 | 0.270 |
Why?
|
| Behavior, Addictive | 2 | 2020 | 137 | 0.260 |
Why?
|
| Stress, Psychological | 1 | 2010 | 345 | 0.260 |
Why?
|
| Facial Expression | 2 | 2024 | 57 | 0.260 |
Why?
|
| Cross-Over Studies | 3 | 2023 | 397 | 0.250 |
Why?
|
| C-Reactive Protein | 6 | 2023 | 206 | 0.250 |
Why?
|
| Heart Rate | 4 | 2020 | 519 | 0.250 |
Why?
|
| Neurotransmitter Agents | 3 | 2013 | 111 | 0.240 |
Why?
|
| Antisocial Personality Disorder | 2 | 2018 | 92 | 0.240 |
Why?
|
| Cues | 2 | 2025 | 189 | 0.230 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2024 | 1973 | 0.220 |
Why?
|
| Euphoria | 1 | 2025 | 47 | 0.220 |
Why?
|
| Serotonin Agents | 2 | 2015 | 13 | 0.220 |
Why?
|
| Fenfluramine | 2 | 2010 | 20 | 0.220 |
Why?
|
| Linear Models | 4 | 2016 | 438 | 0.220 |
Why?
|
| Inflammation | 5 | 2023 | 1068 | 0.210 |
Why?
|
| Smoking | 2 | 2020 | 653 | 0.210 |
Why?
|
| Adult Survivors of Child Abuse | 2 | 2015 | 14 | 0.210 |
Why?
|
| Frontal Lobe | 2 | 2017 | 131 | 0.200 |
Why?
|
| United States | 3 | 2023 | 7767 | 0.200 |
Why?
|
| Prescriptions | 1 | 2023 | 26 | 0.200 |
Why?
|
| Administration, Intranasal | 6 | 2020 | 140 | 0.190 |
Why?
|
| Personality | 2 | 2016 | 140 | 0.190 |
Why?
|
| Outpatients | 1 | 2023 | 105 | 0.190 |
Why?
|
| Self-Injurious Behavior | 3 | 2010 | 115 | 0.190 |
Why?
|
| Suicidal Ideation | 4 | 2016 | 77 | 0.190 |
Why?
|
| Ethanol | 1 | 2024 | 270 | 0.180 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 1874 | 0.180 |
Why?
|
| Interleukin-6 | 4 | 2016 | 281 | 0.180 |
Why?
|
| Malingering | 1 | 2021 | 5 | 0.180 |
Why?
|
| Cannabis | 1 | 2022 | 40 | 0.180 |
Why?
|
| Mental Health | 1 | 2023 | 202 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2023 | 713 | 0.170 |
Why?
|
| Pilot Projects | 3 | 2019 | 938 | 0.170 |
Why?
|
| Caffeine | 1 | 2021 | 86 | 0.170 |
Why?
|
| Facial Recognition | 2 | 2024 | 17 | 0.170 |
Why?
|
| Crime | 1 | 2001 | 38 | 0.170 |
Why?
|
| Self Report | 3 | 2018 | 328 | 0.170 |
Why?
|
| Child | 7 | 2014 | 7626 | 0.170 |
Why?
|
| Neuropsychological Tests | 4 | 2016 | 549 | 0.170 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 2 | 2011 | 48 | 0.160 |
Why?
|
| Narcissism | 1 | 2020 | 3 | 0.160 |
Why?
|
| Burnout, Professional | 1 | 2021 | 113 | 0.160 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2019 | 15 | 0.160 |
Why?
|
| Twins | 2 | 2017 | 65 | 0.160 |
Why?
|
| Administration, Oral | 3 | 2010 | 688 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2025 | 3651 | 0.150 |
Why?
|
| Social Class | 1 | 2020 | 145 | 0.150 |
Why?
|
| Smoking Cessation | 2 | 2020 | 272 | 0.150 |
Why?
|
| Psychomotor Performance | 2 | 2022 | 505 | 0.150 |
Why?
|
| Social Desirability | 1 | 2018 | 12 | 0.150 |
Why?
|
| Deception | 1 | 2018 | 20 | 0.140 |
Why?
|
| Cigarette Smoking | 1 | 2019 | 48 | 0.140 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2018 | 8 | 0.140 |
Why?
|
| Glycerides | 1 | 2018 | 13 | 0.140 |
Why?
|
| Arachidonic Acids | 1 | 2018 | 38 | 0.140 |
Why?
|
| Awareness | 1 | 2018 | 90 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2020 | 252 | 0.140 |
Why?
|
| Case-Control Studies | 5 | 2016 | 1958 | 0.140 |
Why?
|
| Deoxyguanosine | 2 | 2015 | 28 | 0.130 |
Why?
|
| Gray Matter | 1 | 2017 | 43 | 0.130 |
Why?
|
| Prevalence | 2 | 2020 | 1349 | 0.130 |
Why?
|
| Personality Assessment | 2 | 2014 | 99 | 0.130 |
Why?
|
| Intelligence Tests | 2 | 2014 | 39 | 0.130 |
Why?
|
| Biomarkers | 7 | 2016 | 1932 | 0.130 |
Why?
|
| Motion Pictures | 1 | 2016 | 12 | 0.130 |
Why?
|
| Evoked Potentials | 3 | 2022 | 202 | 0.130 |
Why?
|
| Recurrence | 1 | 2020 | 1218 | 0.130 |
Why?
|
| Sex Factors | 1 | 2020 | 1133 | 0.130 |
Why?
|
| National Socialism | 1 | 2016 | 3 | 0.120 |
Why?
|
| Anisotropy | 1 | 2016 | 65 | 0.120 |
Why?
|
| Kynurenine | 1 | 2016 | 23 | 0.120 |
Why?
|
| Brain Mapping | 4 | 2021 | 594 | 0.120 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2016 | 76 | 0.120 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 311 | 0.120 |
Why?
|
| Risk | 1 | 2017 | 668 | 0.120 |
Why?
|
| Valproic Acid | 1 | 2015 | 25 | 0.120 |
Why?
|
| Citalopram | 1 | 2015 | 21 | 0.120 |
Why?
|
| Anxiety | 1 | 2018 | 339 | 0.120 |
Why?
|
| Toxoplasmosis | 1 | 2016 | 70 | 0.110 |
Why?
|
| Receptors, Interleukin-1 Type II | 1 | 2015 | 3 | 0.110 |
Why?
|
| Neurology | 1 | 2016 | 83 | 0.110 |
Why?
|
| Oxytocics | 3 | 2020 | 25 | 0.110 |
Why?
|
| Alcoholism | 1 | 2016 | 191 | 0.110 |
Why?
|
| Psychotropic Drugs | 1 | 2015 | 82 | 0.110 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 163 | 0.110 |
Why?
|
| Dinoprost | 1 | 2014 | 27 | 0.110 |
Why?
|
| Blood Platelets | 2 | 2011 | 156 | 0.100 |
Why?
|
| Depression | 1 | 2018 | 560 | 0.100 |
Why?
|
| Reaction Time | 3 | 2022 | 323 | 0.100 |
Why?
|
| Glutamic Acid | 1 | 2013 | 159 | 0.100 |
Why?
|
| Neuropeptide Y | 1 | 2012 | 31 | 0.100 |
Why?
|
| Psychological Tests | 2 | 2010 | 91 | 0.090 |
Why?
|
| Biogenic Monoamines | 1 | 2012 | 9 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2021 | 1134 | 0.090 |
Why?
|
| Substance P | 1 | 2012 | 62 | 0.090 |
Why?
|
| Time Factors | 4 | 2014 | 5585 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 630 | 0.090 |
Why?
|
| Radioligand Assay | 1 | 2011 | 32 | 0.090 |
Why?
|
| Receptors, Serotonin, 5-HT2 | 1 | 2011 | 15 | 0.090 |
Why?
|
| Hippocampus | 1 | 2015 | 459 | 0.090 |
Why?
|
| Neurotic Disorders | 1 | 2011 | 13 | 0.090 |
Why?
|
| Harm Reduction | 1 | 2011 | 29 | 0.090 |
Why?
|
| Parents | 1 | 2014 | 307 | 0.090 |
Why?
|
| Amino Acids | 1 | 2012 | 262 | 0.090 |
Why?
|
| Serotonin 5-HT1 Receptor Agonists | 1 | 2010 | 4 | 0.080 |
Why?
|
| Motivation | 2 | 2023 | 310 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2012 | 339 | 0.080 |
Why?
|
| Dexamethasone | 1 | 2011 | 351 | 0.080 |
Why?
|
| Diet | 1 | 2012 | 461 | 0.070 |
Why?
|
| Amino Acids, Neutral | 1 | 2008 | 3 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2010 | 599 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2011 | 594 | 0.070 |
Why?
|
| Verbal Behavior | 1 | 2008 | 33 | 0.070 |
Why?
|
| Social Environment | 2 | 2006 | 195 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2010 | 386 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2012 | 3927 | 0.060 |
Why?
|
| Subarachnoid Space | 1 | 2005 | 18 | 0.060 |
Why?
|
| Risk Factors | 4 | 2015 | 5960 | 0.060 |
Why?
|
| Pituitary-Adrenal System | 1 | 2005 | 64 | 0.060 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2005 | 81 | 0.050 |
Why?
|
| Anticipation, Psychological | 1 | 2023 | 10 | 0.050 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 2003 | 18 | 0.050 |
Why?
|
| Consciousness | 1 | 2023 | 32 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2006 | 313 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2016 | 9173 | 0.050 |
Why?
|
| Prolactin | 1 | 2003 | 89 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2003 | 174 | 0.050 |
Why?
|
| Blood Pressure | 2 | 2020 | 929 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2023 | 88 | 0.050 |
Why?
|
| Behavior | 1 | 2003 | 87 | 0.050 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2022 | 12 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 675 | 0.050 |
Why?
|
| Psilocybin | 1 | 2021 | 3 | 0.050 |
Why?
|
| Paroxetine | 2 | 2011 | 26 | 0.040 |
Why?
|
| Visual Perception | 1 | 2024 | 339 | 0.040 |
Why?
|
| Parenting | 2 | 2015 | 79 | 0.040 |
Why?
|
| Age Factors | 1 | 2005 | 1963 | 0.040 |
Why?
|
| Communication | 1 | 2023 | 477 | 0.040 |
Why?
|
| Nicotine | 1 | 2021 | 210 | 0.040 |
Why?
|
| Prefrontal Cortex | 1 | 2001 | 150 | 0.040 |
Why?
|
| Models, Biological | 1 | 2006 | 1810 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 639 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 2550 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 1807 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2017 | 3107 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 2473 | 0.030 |
Why?
|
| Kynurenic Acid | 1 | 2016 | 7 | 0.030 |
Why?
|
| Quinolinic Acid | 1 | 2016 | 9 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 594 | 0.030 |
Why?
|
| Picolinic Acids | 1 | 2016 | 8 | 0.030 |
Why?
|
| Self Concept | 2 | 2008 | 137 | 0.030 |
Why?
|
| Irritable Mood | 1 | 2015 | 10 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 880 | 0.030 |
Why?
|
| Tobacco Use Disorder | 1 | 2016 | 122 | 0.030 |
Why?
|
| Interleukins | 1 | 2015 | 134 | 0.030 |
Why?
|
| Organ Size | 1 | 2015 | 379 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 481 | 0.030 |
Why?
|
| Dopamine | 1 | 2015 | 282 | 0.020 |
Why?
|
| Animals | 2 | 2019 | 28914 | 0.020 |
Why?
|
| Personality Tests | 1 | 2012 | 21 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2014 | 165 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 311 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2012 | 150 | 0.020 |
Why?
|
| Multilevel Analysis | 1 | 2011 | 25 | 0.020 |
Why?
|
| Tritium | 1 | 2011 | 134 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2011 | 21 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2016 | 463 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 217 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 2011 | 138 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 312 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 872 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2011 | 166 | 0.020 |
Why?
|
| Synaptic Membranes | 1 | 2010 | 14 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2014 | 781 | 0.020 |
Why?
|
| Games, Experimental | 1 | 2009 | 11 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 1323 | 0.020 |
Why?
|
| Body Temperature | 1 | 2010 | 131 | 0.020 |
Why?
|
| Child Development | 1 | 2011 | 174 | 0.020 |
Why?
|
| Intelligence | 1 | 2009 | 73 | 0.020 |
Why?
|
| Dendrites | 1 | 2010 | 104 | 0.020 |
Why?
|
| Electroshock | 1 | 2008 | 17 | 0.020 |
Why?
|
| Beverages | 1 | 2008 | 16 | 0.020 |
Why?
|
| Capsules | 1 | 2008 | 38 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2009 | 392 | 0.020 |
Why?
|
| Pain Threshold | 1 | 2008 | 63 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2009 | 873 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 20962 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2008 | 378 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 1167 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2021 | 10286 | 0.020 |
Why?
|
| Sexual Maturation | 1 | 2005 | 35 | 0.010 |
Why?
|
| Decision Making | 1 | 2009 | 694 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2005 | 3974 | 0.010 |
Why?
|